(Post-pandemic Era)-Global The Orally Disintegrating Tablet Excipient Market Segment Research Report 2023

Report ID: 875724 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global The Orally Disintegrating Tablet Excipient Market Segment Research Report 2021
1. Research Scope
2. Market Overview
    2.1 Product Introduction, Application, Picture
    2.2 Global The Orally Disintegrating Tablet Excipient Market by Value
      2.2.1 Global The Orally Disintegrating Tablet Excipient Revenue by Type
      2.2.2 Global The Orally Disintegrating Tablet Excipient Market by Value (%)
    2.3 Global The Orally Disintegrating Tablet Excipient Market by Production
      2.3.1 Global The Orally Disintegrating Tablet Excipient Production by Type
      2.3.2 Global The Orally Disintegrating Tablet Excipient Market by Production (%)

3. The Major Driver of The Orally Disintegrating Tablet Excipient Industry
    3.1 Historical & Forecast Global The Orally Disintegrating Tablet Excipient Demand
    3.2 Largest Application for The Orally Disintegrating Tablet Excipient (2017-2027)
    3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The Orally Disintegrating Tablet Excipient Market
    4.1 Regional Market Size in Terms of Production & Demand (2021)
    4.2 Regional Market Share in Terms of Revenue (2019-2027) 
    4.3 Concentration Ratio (CR5& CR10) of The Orally Disintegrating Tablet Excipient Market
    4.4 Mergers & Acquisitions, Expansion Plans

5. US The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    5.1 Current and Estimated Production Breakdown by Type
    5.2 Current and Estimated Demand Breakdown by Type
    5.3 Current and Estimated Demand Breakdown by Application
    5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    6.1 Current and Estimated Production Breakdown by Type
    6.2 Current and Estimated Demand Breakdown by Type
    6.3 Current and Estimated Demand Breakdown by Application
    6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    7.1 Current and Estimated Production Breakdown by Type
    7.2 Current and Estimated Demand Breakdown by Type
    7.3 Current and Estimated Demand Breakdown by Application
    7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    8.1 Current and Estimated Production Breakdown by Type
    8.2 Current and Estimated Demand Breakdown by Type
    8.3 Current and Estimated Demand Breakdown by Application
    8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    9.1 Current and Estimated Production Breakdown by Type
    9.2 Current and Estimated Demand Breakdown by Type
    9.3 Current and Estimated Demand Breakdown by Application
    9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    10.1 Current and Estimated Production Breakdown by Type
    10.2 Current and Estimated Demand Breakdown by Type
    10.3 Current and Estimated Demand Breakdown by Application
    10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    11.1 Current and Estimated Production Breakdown by Type
    11.2 Current and Estimated Demand Breakdown by Type
    11.3 Current and Estimated Demand Breakdown by Application
    11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The Orally Disintegrating Tablet Excipient Average Price Trend
    12.1 Market Price for Each Type of The Orally Disintegrating Tablet Excipient in US (2017-2021)
    12.2 Market Price for Each Type of The Orally Disintegrating Tablet Excipient in Europe (2017-2021)
    12.3 Market Price for Each Type of The Orally Disintegrating Tablet Excipient in China (2017-2021)
    12.4 Market Price for Each Type of The Orally Disintegrating Tablet Excipient in Japan (2017-2021)
    12.5 Market Price for Each Type of The Orally Disintegrating Tablet Excipient in India (2017-2021)
    12.6 Market Price for Each Type of The Orally Disintegrating Tablet Excipient in Korea (2017-2021)
    12.7 Market Price for Each Type of The Orally Disintegrating Tablet Excipient in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
    13.1 The Orally Disintegrating Tablet Excipient Industrial Chain Analysis
    13.2 Downstream
    13.3 Impact of COVID-19
    13.4 Technology Trends of The Orally Disintegrating Tablet Excipient

14. The Orally Disintegrating Tablet Excipient Competitive Landscape
     14.1 BASF
        14.1.1 BASF Company Profiles
        14.1.2 BASF Product Introduction
        14.1.3 BASF The Orally Disintegrating Tablet Excipient Sales, Revenue (2017-2021)
        14.1.4 Strategic initiatives
     14.2 Ashland
        14.2.1 Ashland Company Profiles
        14.2.2 Ashland Product Introduction
        14.2.3 Ashland The Orally Disintegrating Tablet Excipient Sales, Revenue (2017-2021)
        14.2.4 Strategic initiatives
     14.3 ABF Ingredients
        14.3.1 ABF Ingredients Company Profiles
        14.3.2 ABF Ingredients Product Introduction
        14.3.3 ABF Ingredients The Orally Disintegrating Tablet Excipient Sales, Revenue (2017-2021)
        14.3.4 Strategic initiatives
     14.4 JRS Pharma
        14.4.1 JRS Pharma Company Profiles
        14.4.2 JRS Pharma Product Introduction
        14.4.3 JRS Pharma The Orally Disintegrating Tablet Excipient Sales, Revenue (2017-2021)
        14.4.4 Strategic initiatives
     14.5 Merck KGaA
        14.5.1 Merck KGaA Company Profiles
        14.5.2 Merck KGaA Product Introduction
        14.5.3 Merck KGaA The Orally Disintegrating Tablet Excipient Sales, Revenue (2017-2021)
        14.5.4 Strategic initiatives
     14.6 Roquette
        14.6.1 Roquette Company Profiles
        14.6.2 Roquette Product Introduction
        14.6.3 Roquette The Orally Disintegrating Tablet Excipient Sales, Revenue (2017-2021)
        14.6.4 Strategic initiatives
     14.7 Shin-Etsu
        14.7.1 Shin-Etsu Company Profiles
        14.7.2 Shin-Etsu Product Introduction
        14.7.3 Shin-Etsu The Orally Disintegrating Tablet Excipient Sales, Revenue (2017-2021)
        14.7.4 Strategic initiatives
     14.8 Evonik
        14.8.1 Evonik Company Profiles
        14.8.2 Evonik Product Introduction
        14.8.3 Evonik The Orally Disintegrating Tablet Excipient Sales, Revenue (2017-2021)
        14.8.4 Strategic initiatives
     14.9 DFE Pharma
        14.9.1 DFE Pharma Company Profiles
        14.9.2 DFE Pharma Product Introduction
        14.9.3 DFE Pharma The Orally Disintegrating Tablet Excipient Sales, Revenue (2017-2021)
        14.9.4 Strategic initiatives
     14.10 Meggle Pharma
        14.10.1 Meggle Pharma Company Profiles
        14.10.2 Meggle Pharma Product Introduction
        14.10.3 Meggle Pharma The Orally Disintegrating Tablet Excipient Sales, Revenue (2017-2021)
        14.10.4 Strategic initiatives
     14.11 Anhui Sunhere Pharmaceutical
     14.12 Fuji Chemical Industries
     14.13 Daicel Corporation
     14.14 McePharma (Vivesa holding)
     14.15 Cargill Incorporated
15. Conclusion


List of Tables and Figures

    Figure 1. Total Demand by Application of The Orally Disintegrating Tablet Excipient Industry (Volume)
    Figure 2. The Orally Disintegrating Tablet Excipient Production & Demand by Regions in 2021
    Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
    Figure 4. The Top 10 and 5 Players Market Share by The Orally Disintegrating Tablet Excipient Revenue in 2021
    Figure 5. US The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    Figure 6. Production Breakdown by Type (%)
    Figure 7. Demand Breakdown by Type (%)
    Figure 8. Demand Breakdown by Application (%)
    Figure 9. Revenue Breakdown by Type (%)
    Figure 10. Revenue Breakdown by Application (%)
    Figure 11. Europe The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    Figure 12. Production Breakdown by Type (%)
    Figure 13. Demand Breakdown by Type (%)
    Figure 14. Demand Breakdown by Application (%)
    Figure 15. Revenue Breakdown by Type (%)
    Figure 16. Revenue Breakdown by Application (%)
    Figure 17. China The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    Figure 18. Production Breakdown by Type (%)
    Figure 19. Demand Breakdown by Type (%)
    Figure 20. Demand Breakdown by Application (%)
    Figure 21. Current and Estimated Revenue Breakdown by Type
    Figure 22. Revenue Breakdown by Type (%)
    Figure 23. Revenue Breakdown by Application (%)
    Figure 24. Japan The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    Figure 25. Production Breakdown by Type (%)
    Figure 26. Demand Breakdown by Type (%)
    Figure 27. Demand Breakdown by Application (%)
    Figure 28. Revenue Breakdown by Type (%)
    Figure 29. Revenue Breakdown by Application (%)
    Figure 30. India The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    Figure 31. Production Breakdown by Type (%)
    Figure 32. Demand Breakdown by Type (%)
    Figure 33. Demand Breakdown by Application (%)
    Figure 34. Revenue Breakdown by Type (%)
    Figure 35. Revenue Breakdown by Application (%)
    Figure 36. Korea The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    Figure 37. Production Breakdown by Type (%)
    Figure 38. Demand Breakdown by Type (%)
    Figure 39. Demand Breakdown by Application (%)
    Figure 40. Revenue Breakdown by Type (%)
    Figure 41. Revenue Breakdown by Application (%)
    Figure 42. Southeast Asia The Orally Disintegrating Tablet Excipient Production, Demand (2017-2027)
    Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
    Figure 44. Production Breakdown by Type (%)
    Figure 45. Demand Breakdown by Type (%)
    Figure 46. Revenue Breakdown by Type (%)
    Figure 47. Revenue Breakdown by Application (%)
    Figure 48. Industrial Chain
    Table 1. Top Manufacturers and Market Segmentation
    Table 2. Product Introduction, Application, Picture
    Table 3. The Orally Disintegrating Tablet Excipient Revenue, by Type (Million USD) (2017-2027)
    Table 4. The Orally Disintegrating Tablet Excipient Production, by Type (K Unit) (2017-2027)
    Table 5. The Orally Disintegrating Tablet Excipient Demand (K Unit) by Application (2017-2027)
    Table 6. The Orally Disintegrating Tablet Excipient Demand (Million USD) by Application (2017-2027)
    Table 7. The Major Downstream Company in China
    Table 8. Regional Market Share in Terms of Production & Demand (2021)
    Table 9. Regional Market Share in Terms of Revenue (2021&2027)
    Table 10. Ranking of Global Top The Orally Disintegrating Tablet Excipient Companies by Revenue, Concentration Ratio in 2021
    Table 11. Mergers & Acquisitions, Expansion Plans
    Table 12. US The Orally Disintegrating Tablet Excipient Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 16. Current and Estimated Revenue Breakdown by Type
    Table 17. Current and Estimated Revenue Breakdown by Application
    Table 18. Europe The Orally Disintegrating Tablet Excipient Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 22. Current and Estimated Revenue Breakdown by Type
    Table 23. Current and Estimated Revenue Breakdown by Application
    Table 24. China The Orally Disintegrating Tablet Excipient Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 25. Table Current and Estimated Production Breakdown by Type
    Table 26. Current and Estimated Demand Breakdown by Type
    Table 27. Current and Estimated Demand Breakdown by Application
    Table 28. Current and Estimated Revenue Breakdown by Application
    Table 29. Japan The Orally Disintegrating Tablet Excipient Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 33. Current and Estimated Revenue Breakdown by Type
    Table 34. Current and Estimated Revenue Breakdown by Application
    Table 35. India The Orally Disintegrating Tablet Excipient Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 39. Current and Estimated Revenue Breakdown by Type
    Table 40. Current and Estimated Revenue Breakdown by Application
    Table 41. Korea The Orally Disintegrating Tablet Excipient Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 45. Current and Estimated Revenue Breakdown by Type
    Table 46. Current and Estimated Revenue Breakdown by Application
    Table 47. Southeast Asia The Orally Disintegrating Tablet Excipient Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 50. Current and Estimated Revenue Breakdown by Type
    Table 51. Current and Estimated Revenue Breakdown by Application
    Table 52. Market Price (USD/Unit) for Each Type of The Orally Disintegrating Tablet Excipient in US (2017-2021)
    Table 53. Market Price (USD/Unit) for Each Type of The Orally Disintegrating Tablet Excipient in Europe (2017-2021)
    Table 54. Market Price (USD/Unit) for Each Type of The Orally Disintegrating Tablet Excipient in China (2017-2021)
    Table 55. Market Price (USD/Unit) for Each Type of The Orally Disintegrating Tablet Excipient in Japan (2017-2021)
    Table 56. Market Price (USD/Unit) for Each Type of The Orally Disintegrating Tablet Excipient in India (2017-2021)
    Table 57. Market Price (USD/Unit) for Each Type of The Orally Disintegrating Tablet Excipient in Korea (2017-2021)
    Table 58. Market Price (USD/Unit) for Each Type of The Orally Disintegrating Tablet Excipient in Southeast Asia (2017-2021)
    Table 59. Key Downstream Customer in Each Application Field
    Table 60. BASF Profiles
    Table 61. BASF The Orally Disintegrating Tablet Excipient Product Introduction
    Table 62. BASF The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 63. BASF Strategic initiatives
    Table 64. Ashland Profiles
    Table 65. Ashland The Orally Disintegrating Tablet Excipient Product Introduction
    Table 66. Ashland The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 67. Ashland Strategic initiatives
    Table 68. ABF Ingredients Profiles
    Table 69. ABF Ingredients The Orally Disintegrating Tablet Excipient Product Introduction
    Table 70. ABF Ingredients The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 71. ABF Ingredients Strategic initiatives
    Table 72. JRS Pharma Profiles
    Table 73. JRS Pharma The Orally Disintegrating Tablet Excipient Product Introduction
    Table 74. JRS Pharma The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 75. JRS Pharma Strategic initiatives
    Table 76. Merck KGaA Profiles
    Table 77. Merck KGaA The Orally Disintegrating Tablet Excipient Product Introduction
    Table 78. Merck KGaA The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 79. Merck KGaA Strategic initiatives
    Table 80. Roquette Profiles
    Table 81. Roquette The Orally Disintegrating Tablet Excipient Product Introduction
    Table 82. Roquette The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 83. Roquette Strategic initiatives
    Table 84. Shin-Etsu Profiles
    Table 85. Shin-Etsu The Orally Disintegrating Tablet Excipient Product Introduction
    Table 86. Shin-Etsu The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 87. Shin-Etsu Strategic initiatives
    Table 88. Evonik Profiles
    Table 89. Evonik The Orally Disintegrating Tablet Excipient Product Introduction
    Table 90. Evonik The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 91. Evonik Strategic initiatives
    Table 92. DFE Pharma Profiles
    Table 93. DFE Pharma The Orally Disintegrating Tablet Excipient Product Introduction
    Table 94. DFE Pharma The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 95. DFE Pharma Strategic initiatives
    Table 97. Meggle Pharma Profiles
    Table 98. Meggle Pharma The Orally Disintegrating Tablet Excipient Product Introduction
    Table 99. Meggle Pharma The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 100. Meggle Pharma Strategic initiatives
    Table 101. Anhui Sunhere Pharmaceutical Profiles
    Table 102. Anhui Sunhere Pharmaceutical The Orally Disintegrating Tablet Excipient Product Introduction
    Table 103. Anhui Sunhere Pharmaceutical The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 104. Anhui Sunhere Pharmaceutical Strategic initiatives
    Table 105. Fuji Chemical Industries Profiles
    Table 106. Fuji Chemical Industries The Orally Disintegrating Tablet Excipient Product Introduction
    Table 107. Fuji Chemical Industries The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 108. Fuji Chemical Industries Strategic initiatives
    Table 109. Daicel Corporation Profiles
    Table 110. Daicel Corporation The Orally Disintegrating Tablet Excipient Product Introduction
    Table 111. Daicel Corporation The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 112. Daicel Corporation Strategic initiatives
    Table 113. McePharma (Vivesa holding) Profiles
    Table 114. McePharma (Vivesa holding) The Orally Disintegrating Tablet Excipient Product Introduction
    Table 115. McePharma (Vivesa holding) The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 116. McePharma (Vivesa holding) Strategic initiatives
    Table 117. Cargill Incorporated Profiles
    Table 118. Cargill Incorporated The Orally Disintegrating Tablet Excipient Product Introduction
    Table 119. Cargill Incorporated The Orally Disintegrating Tablet Excipient Sales (Unit), Revenue (Million USD) (2017-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global The Orally Disintegrating Tablet Excipient Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global The Orally Disintegrating Tablet Excipient Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global The Orally Disintegrating Tablet Excipient Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports